The National Institutes of Health (NIH) is offering a funding opportunity for revision applications aimed at enhancing cancer research through the incorporation of novel technologies developed under the NCI Innovative Molecular Analysis Technologies (IMAT) program. This initiative encourages currently funded NCI P50 specialized centers to expand their research by integrating new technical approaches or instruments, thereby promoting interdisciplinary collaboration and independent validation of emerging technologies. A total of approximately $600,000 is available for three awards, with applicants able to request up to $150,000 annually for a maximum of two years. The application period opens on March 1, 2024, with a submission deadline of October 1, 2024, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.